Groundbreaking clinical trial underway to improve vision in

/PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen,...

Related Keywords

Adelaide , South Australia , Australia , Melbourne , Victoria , Kiora , New South Wales , Australian , Greg Plunkett , Nicole Kanellopoulos Remy , Brianm Strem , Robert Casson , Kiora Pharmaceuticals , Linkedin , Twitter , Kiora Pharmaceuticals Inc , Nasdaq , Contract Research Organisation , Putting Australian , Royal Adelaide Hospital , Retinitis Pigmentosa , Royal Adelaide , Professor Robert Casson , Chief Executive Officer , Remy Arena , Ocular Presentation , Rheumatoid Arthritis , Dihydroorotate Dehydrogenase , Accelagen ,